Evidence map›Paper›PMID 11035769›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Human lung cancer and p53: the interplay between mutagenesis and selection.

S N Rodin, A S Rodin

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Changing mutational and adaptive landscapes and the genesis of cancer.Biochimica et biophysica acta. Reviews on cancer · 2017
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. [Advances of hypoxia and lung cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2013
    Review
  15. Article
  16. p53 Mutagenesis by benzo[a]pyrene derived radical cations.Chemical research in toxicology · 2012
    Article
  17. Nuclear factor-κB: a key regulator in health and disease of lungs.Archivum immunologiae et therapiae experimentalis · 2011
    Review
  18. Article
  19. Article
  20. Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

S N RodinBiology Department, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010, USA.
A S Rodin
City Of Hope National Medical Center · US

Funding

TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONSR01CA076573 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI HOLMQUIST, GERALD P · 1998 to 2000
$115k
NCI NIH HHS CA76573
6 · The paper itself

Abstract

It is an almost consensus opinion that the major carcinogenic risk of tobacco smoke is in its direct mutagenic action on DNA of cancer-related genes. The key data supposedly linking smoke-induced mutations to lung cancer were obtained from the adduct spectrum of the p53 tumor suppressor gene. Results of our analysis of p53 mutations compiled from the International Agency for Research on Cancer p53 database (April 1999 update) and from the literature point to a different causative link. Our new analytical tests focused on complementary base substitutions and showed that it is strand-specific repair of primary lesions and site-specific selection of the resultant mutations that determine the lung cancer-specific hot spots of G:C to T:A transversions along the p53 gene and also their increased abundance in lung tissues as compared with smoke-inaccessible tissues. However, on each of the two strands of p53 DNA, our tests revealed no significant difference between smokers and nonsmokers, either in the frequency of different types of mutations or in the frequency of their occurrence along the p53 gene. Moreover, in both smokers and nonsmokers, there was the same frequency of lung tumors with silent p53 mutations. Accordingly, we offer here a selection-based explanation of why lung cancers with nonsilent p53 mutations are more common in smokers than in nonsmokers. We conclude that physiological stresses (not necessarily genotoxic) aggravated by smoking are the leading risk factor in the p53-associated etiology of lung cancer.

Indexed as

Genes, p53MutationSelection, Genetic7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAdenocarcinomaBiomarkers, TumorCodonHumansLung NeoplasmsSmoking7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideBiomarkers, TumorCodon

Identifiers

PMID11035769
PMCPMC17326
OpenAlexW2120347944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.